- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|compound 25 [PMID: 21028894]|
|Henatinib is a kinase inhibitor with some selectivity for VEGFR2 (KDR). Discovery was reported by Cho et al. (2010), the same article that disclosed famitinib . The name henatinib is linked to the structure of 'compound 25' in the article by Gu et al. (2010) that describes a method for detecting and quantifying henatinib maleate in rat plasma .
Henatinib is a 'pseudo' INN, that takes the form of an INN for a kinase inhibitor, but has not been submitted to the World Health Organisation for ratification.
|GtoPdb PubChem SID||363894224|
|Search Google for chemical match using the InChIKey||MCTXSDCWFQAGFS-UEXNTNOUSA-N|
|Search Google for chemicals with the same backbone||MCTXSDCWFQAGFS|
|Search UniChem for chemical match using the InChIKey||MCTXSDCWFQAGFS-UEXNTNOUSA-N|
|Search UniChem for chemicals with the same backbone||MCTXSDCWFQAGFS|